QR Cargo, Envirotainer to promote sustainability for pharma transport
Collaboration underscores ongoing commitment of both organisations to investing in latest technologies
Qatar Airways Cargo and Envirotainer have joined forces to offer a more sustainable solution for shipping temperature-sensitive pharmaceuticals.
"By capitalising on both organisations’ extensive network capabilities, along with Envirotainer's cutting-edge Releye solution, CO2 emissions for shipments can be reduced by up to 90 percent compared to other solutions," says a release from Qatar Cargo. "The Releye RLP and RLP solutions also ensure precise temperature control throughout the entire transportation process, meaning this partnership guarantees the utmost integrity and quality of temperature sensitive cargo like never before."
Miguel Rodriguez, Head, Cargo Products, Qatar Airways says: "I am thrilled to announce the reinforcement of our strategic partnership with Envirotainer, a global leader in temperature-controlled air transportation solutions. This collaboration marks a significant milestone for Qatar Airways Cargo as we continue to enhance our capabilities in delivering pharmaceuticals and other temperature-sensitive cargo worldwide. At Qatar Airways Cargo, we understand the criticality of maintaining the cold chain and ensuring that pharmaceuticals reach their destination in optimal conditions. By joining forces with Envirotainer, we can offer our customers seamless access to their industry-leading containers, which are specifically designed to meet the stringent requirements of the pharmaceutical industry."
Akos Balkanyi, Global Key Account Manager, Envirotainer adds: "Through the optimisation of our operations and investment in cutting-edge solutions such the Releye units, we are actively reducing our environmental impact and contributing to a greener future reducing up to 90 percent of our CO2 emissions. We are excited about this collaboration and the positive impact it will have on our customers and the industry as a whole.”
The collaboration underscores the ongoing commitment of both organisations to investing in the latest technologies to meet the needs of the life sciences sector and is poised to make a long-term positive impact on customers and the industry for the future, the release added.